43 results
8-K
EX-99.1
NGM
Ngm Biopharmaceuticals Inc
11 Mar 24
NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results
4:13pm
to the programs that we believe have the greatest potential both in the near- and long-term.”
Key Fourth Quarter and Recent Highlights
Solid Tumor Oncology … that it believes have the greatest potential both in the near- and long-term and; research and development and discovery engine output; the expected timing
SC 14D9
NGM
Ngm Biopharmaceuticals Inc
8 Mar 24
Tender offer solicitation
5:21pm
The Company Board has adopted a non-employee director compensation policy, designed to enable NGM Bio to attract and retain, on a long-term basis, highly … -and long-term financing needs.
On October 31, 2023, The Column Group LLC, an affiliate of TCG, entered into a non-disclosure agreement with the Company
SC TO-T
EX-99
NGM
Ngm Biopharmaceuticals Inc
8 Mar 24
Third party tender offer statement
4:53pm
resources or taking advantage of any in-licensing opportunities within TCG’s portfolio. The participants also discussed the Company’s short- and long-term financing … a long-term stockholder of NGM.
On December 29, 2023, TCG filed an amendment to their Schedule 13D disclosing the Board Letter and TCG’s interest
8-K
EX-99.1
47q e0k7mppuyjd5cog
4 Apr 23
Cost Associated with Exit or Disposal Activities
4:06pm